Rick Kapur: Current Understanding of FNAIT Regarding Diagnostics, Pathophysiology and Management
Rick Kapur, Research Group Leader at Sanquin, Principal Investigator at Amsterdam UMC shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood, adding:
“Happy to see this paper out where we highlight our current understanding of Fetal-neonatal alloimmune thrombocytopenia (FNAIT) regarding diagnostics, pathophysiology and management.
New developments support the importance of identifying predictive biomarkers of fetal risk to guide antenatal management and of preventing affected pregnancies ideally by screening all pregnancies followed by prophylaxis.
With James Bussel and Jory Hirshman.
Free access till August 14.”
Title: Anti–HPA-1a fetal-neonatal alloimmune thrombocytopenia: reframing diagnostics, pathophysiology, and management
Authors: James B. Bussel, Jory M. Hirshman, Rick Kapur
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 28, 2026, 09:55Utkarsh Pandey: Japan Approves Wayrilz for ITP Patients
-
Jun 28, 2026, 09:41Sung-mok Jung: How Environmental Drivers Influence SFTS Occurrence
-
Jun 28, 2026, 05:17Burcu Tunakan: Turning Collaboration into Better Outcomes for People with Hemophilia
-
Jun 28, 2026, 05:08Kathrine Kaspersen: The Power of Voluntary Plasma Donation
-
Jun 28, 2026, 04:55Sana Helani: Challenging Common Assumptions in Anemia Management
-
Jun 28, 2026, 04:55Samwel Mikaye: The Collapse of Coagulation Control in Disseminated Intravascular Coagulation
-
Jun 28, 2026, 04:45Abolfazl Miri: Improving ITP Diagnosis with Readily Available Hematological Indices
-
Jun 28, 2026, 04:22Jensa Morris: Why Low Molecular Weight Heparins Should Be the First Choice for VTE
-
Jun 28, 2026, 03:57Sara Zalghout: Navigating the Often-Unspoken Challenges of Academia at ISTH 2026